Pediatrix Medical Group (MD) Competitors

Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, community ranking, valuation, institutional ownership, analyst recommendations and media sentiment.

Do institutionals and insiders hold more shares of AMED or MD?

94.4% of Amedisys shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 2.1% of Amedisys shares are held by insiders. Comparatively, 2.0% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the media prefer AMED or MD?

In the previous week, Amedisys and Amedisys both had 3 articles in the media. Pediatrix Medical Group's average media sentiment score of 1.53 beat Amedisys' score of 1.36 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amedisys	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pediatrix Medical Group	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has higher valuation & earnings, AMED or MD?

Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amedisys	$2.35B	1.30	-$9.75M	$1.31	70.76
Pediatrix Medical Group	$2.01B	0.60	-$60.41M	-$1.20	-11.79

Does the MarketBeat Community prefer AMED or MD?

Pediatrix Medical Group received 12 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.21% of users gave Pediatrix Medical Group an outperform vote while only 58.58% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Amedisys	Outperform Votes 495 58.58%	Underperform Votes 350 41.42%
Pediatrix Medical Group	Outperform Votes 507 60.21%	Underperform Votes 335 39.79%

Is AMED or MD more profitable?

Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -4.92%. Pediatrix Medical Group's return on equity of 15.47% beat Amedisys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amedisys	3.57%	12.20%	6.74%
Pediatrix Medical Group	-4.92%	15.47%	5.64%

Which has more risk & volatility, AMED or MD?

Amedisys has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500.

Do analysts prefer AMED or MD?

Amedisys currently has a consensus price target of $101.00, suggesting a potential upside of 8.95%. Pediatrix Medical Group has a consensus price target of $17.08, suggesting a potential upside of 20.71%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe Pediatrix Medical Group is more favorable than Amedisys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amedisys	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pediatrix Medical Group	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Pediatrix Medical Group beats Amedisys on 9 of the 17 factors compared between the two stocks.